Ketamine Treatment Market Will Generate Record Revenue by 2029
The global ketamine
treatment market is anticipated to grow at a CAGR of 43.7% during the forecast
period (2023-2030). Ketamine has been widely used in the treatment of various
conditions, including major depressive disorder, treatment-resistant depression
(TRD), bipolar depression, post-traumatic stress disorder, anxiety disorders,
chronic pain management, and migraine or headache management. Ketamine is also
been used in the form of infusion therapy and nasal spray, and has been found
to be effective in reducing symptoms of these conditions.
The primary factor supporting the
market growth includes the growing demand and advancements in telehealth.
Post-COVID-19 pandemic, the number of people receiving ketamine via
telemedicine has been soared owing to the lockdown restrictions imposed globally
by the federal government of all the nations. One rule change allowed providers
to prescribe controlled substances including ketamine without first seeing the
patient in person.
The adoption of telemedicine and
virtual care solutions is a significant driving factor in the globally ketamine
treatment market. It increases access to treatment, especially in areas where
in-person options are minimal. For instance, in September 2022, Braxia
Scientific Corp. launched KetaMD in Florida. KetaMD accepted new patients
and finished their first ketamine treatments. Eligible patients, as determined
by one of KetaMD's certified Florida healthcare practitioners, received
medically supervised therapies while at home, virtually directed by registered
nurses with mental health competence.
Furthermore, Ketamine has been
studied for its potential in treating depression and other mood disorders which
have not responded to other forms of treatment. It has been seen to offer a
possible solution to those struggling with treatment-resistant conditions. in
October 2023,Victoria’s first public ketamine clinic has opened It is employing
the anesthetic, that is often used as a recreational substance, to assist
patients suffering from difficult-to-treat depression.
To Request a Sample of our Report on Ketamine Treatment
Market: https://www.omrglobal.com/request-sample/ketamine-treatment-market
•
The market number available for – 2022-2030
•
Base year- 2022
•
Forecast period- 2023-2030
Segment
Covered-
·
By Route of Administration
·
By Application
·
By End User
Regions Covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
•
Competitive Landscape- includes Core One Labs
Inc., Enso Discoveries, LLC., Johnson & Johnson Pvt. Ltd., Ketamine
Research Institute, Ketamine Wellness Centers, and others.
Ketamine Treatment
Market Report Segment
By Route of
Administration
•
Oral
•
Infusions
•
Nasal Spray
By Application
•
Treatment-Resistant Depression (TRD)
•
Anxiety Disorder
•
Post-Traumatic Stress Disorder (PTSD)
•
Others (Anesthesia and Sedation, Bipolar Depression, and
Chronic Pain Management)
By End-User
•
Hospitals and Medical Centers
•
Specialized Ketamine Clinics
•
Psychiatric Hospitals
•
Others (Rehabilitation Centers, Primary Care Physicians,
Individual Patients and Research and Academic Institutions)
A full Report of Ketamine Treatment Market is Available @ https://www.omrglobal.com/industry-reports/ketamine-treatment-market
Ketamine Treatment Market Report Segment by Region
North America
· United
States
· Canada
Europe
· UK
· Germany
· Spain
· France
· Italy
· Rest
of Europe
Asia-Pacific
· India
· China
· Japan
· South
Korea
· Rest
of APAC
Rest of the World
•
Latin America
•
Middle East and Africa
Company Profiles
•
Core One Labs Inc.
•
Enso Discoveries, LLC.
•
Johnson & Johnson Pvt. Ltd.
•
Ketamine Research Institute
•
Ketamine Wellness Centers
•
Klarisana
•
Koch Industries, Inc.
•
Mindbloom, Inc.
•
Pfizer
•
saveminds.co.uk
•
Stella MSO LLC
•
Unión QuĆmico FarmacĆ©utica, S.A.U.
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
For More Customized Data,
Request for Report Customization @ https://www.omrglobal.com/report-customization/ketamine-treatment-market
About Orion Market Research
Orion Market
Research (OMR) is a market research and consulting company known for its crisp
and concise reports. The company is equipped with an experienced team of
analysts and consultants. OMR offers quality syndicated research reports,
customized research reports, consulting and other research-based services. The
company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services
through another subsidiary Encanto Technologies.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment